SCHEMBL6048540

SCHEMBL6048540

CN(C)Cc1ccccc1-c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 8/20 0.45
CYP3A4 P08684 7/20 0.45
CYP1A2 P05177 7/20 0.45
CLK4 Q9HAZ1 2/20 0.45
TACR1 P25103 1/20 0.45
CYP2C19 P33261 3/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC6A4 P31645 4/20 0.42
HTR2A P28223 1/20 0.42
P2RY1 P47900 1/20 0.41
KCNH2 Q12809 1/20 0.41
SLC6A2 P23975 3/20 0.40
SLC6A3 Q01959 2/20 0.40
KDM4E B2RXH2 1/20 0.40
BACE1 P56817 2/20 0.39
AR P10275 2/20 0.39
CD274 Q9NZQ7 1/20 0.39
F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6048557 0.99 CYP2D6 (0.44) CYP2D6CYP3A4CYP1A2CLK4TACR1
SCHEMBL6048497 0.83 SLC6A4 (0.54) CYP2D6CYP3A4CYP1A2CLK4TACR1
Hydrochloric Acid SCHEMBL6048489 0.82 SLC6A4 (0.52) CYP2D6CYP3A4CYP1A2CLK4TACR1
SCHEMBL6048567 0.79 PTGS2 (0.50) CYP2D6CYP3A4CYP1A2CLK4CYP2C19
SCHEMBL6048482 0.79 AR (0.44) CYP2D6CYP3A4CYP1A2CLK4TACR1
Hydrochloric Acid SCHEMBL6048542 0.78 PTGS2 (0.49) CYP2D6CYP3A4CYP1A2CLK4CYP2C19
Hydrochloric Acid SCHEMBL6048535 0.78 AR (0.44) CYP2D6CYP3A4CYP1A2CLK4TACR1
SCHEMBL3465931 0.78 CYP2D6 (0.48) CYP2D6CYP3A4CYP1A2CLK4CYP2C19
SCHEMBL5094478 0.77 CYP1A2 (0.47) CYP2D6CYP3A4CYP1A2CLK4CYP2C19
SCHEMBL3161247 0.77 CYP1A2 (0.47) CYP2D6CYP3A4CYP1A2CLK4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP claimed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US claimed
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives GRUENENTHAL GMBH (DE) 2002-12-26 US claimed
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP disclosed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US disclosed
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives GRUENENTHAL GMBH (DE) 2002-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives LIPA, PKD1, PKD2 CYP2D6 60/4885CYP3A4 115/4885CYP1A2 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.